Press Releases
Clinical Trials
Signant Health Launches Partner Program to Team with CRO’s Committed to Improving Clinical Trials with Patient Centric Technology
Signant Health , a leading provider of technology for clinical research, launches the Signant Health Partner Program, a significant investment the company is making to enable clinical research organizations (CROs) to better serve sponsors in the areas of Patient...
Press Releases
Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 Antibody
Aevi Genomic Medicine, Inc. announced that it has obtained the right to exercise an exclusive global license for MEDI2338, a Phase 2-ready fully human monoclonal antibody (mAb) that targets interleukin 18 (IL-18). The Company plans to initially develop MEDI2338...
IT & Data Management
Boston Analytical Continues Expansion with Office in Cambridge MA
Boston Analytical, a leading provider of analytical and microbiological testing to the pharmaceutical industry, has opened an office in downtown Cambridge. This expansion comes two years after opening a 30,000 square foot, state-of-the-art facility in Salem, NH, and one...
Press Releases
Pre-scored chip substrates provide new options for manufacturers of innovative diagnostic consumables
SCHOTT NEXTERION® PreScora will be featured at the American Association of Clinical Chemistry’s annual scientific meeting and clinical lab expo in Anaheim, Ca.
Biotech companies have made remarkable strides developing lab-on-a-chip (LoaC) technology — ever smaller chips that integrate laboratory...
IT & Data Management
The “Papageorgiou” General Hospital of Thessaloniki joins Clinerion’s hospital network, consolidating Patient Network Explorer coverage in Greece
Geniko Nosokomeio Thessalonikis “Papageorgiou” brings its patients and physicians quicker access to innovative medical treatments by joining Clinerion’s Patient Network Explorer platform.
Based in the city of Thessaloniki, Greece, “Papageorgiou” General Hospital has 746 beds and specializes in research on...
IT & Data Management
GNA Biosolutions Closes 13.5M Series C Financing Round Backed by a US EU consortium
GNA Biosolutions GmbH, a molecular diagnostics company based in Germany, announced that it has completed a $13.5M round of financing.
The Series C financing round was joined by new investors including GreyBird Ventures, Occident, and Wachstumsfonds Bayern, and existing investors...
Press Releases
CPhI MEA expert growing domestic manufacturing is creating new opportunities for international Pharma in the Middle East
CPhI Middle East expert Emad Shabbir, Director at EMAD Trade House, states favorable conditions and legislative regulations in Saudi Arabia are resulting in a boom of manufacturers and CMOs partnerships with international pharma companies. With the strategic cooperation between...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
